|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9200 EUR | +1.77% |
|
0.00% | +54.36% |
| 06-11 | Triple update for Biosynex |  |
| 06-11 | An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 0.942 | 1.57 | 1.205 |
| Spread/Res. | -2.34% | -41.40% | -23.65% |
| Spread/Supp. | +3.84% | +25.00% | +93.28% |
| Support | 0.886 | 0.736 | 0.476 |
- Stock Market
- Stocks
- ALBIO Stock
- Charts Biosynex
Select your edition
All financial news and data tailored to specific country editions
